Feist, E., Fleischmann, R. M., Fatenejad, S., Bukhanova, D., Grishin, S., Kuzkina, S., . . . Smolen, J. S. Olokizumab plus methotrexate: Safety and efficacy over 106 weeks of treatment. IMA-PRESS LLC.
Chicago Style (17th ed.) CitationFeist, Eugen, et al. Olokizumab Plus Methotrexate: Safety and Efficacy over 106 Weeks of Treatment. IMA-PRESS LLC.
MLA (9th ed.) CitationFeist, Eugen, et al. Olokizumab Plus Methotrexate: Safety and Efficacy over 106 Weeks of Treatment. IMA-PRESS LLC.
Warning: These citations may not always be 100% accurate.